Also trades as: BIOCON.BO (BSE) · $vol 1M
BIOCON.NS NSE
Biocon Limited
1W: +3.4%
1M: +19.9%
3M: +14.7%
YTD: +16.8%
1Y: +28.0%
3Y: +117.4%
5Y: +12.6%
₹429.60 ($4.49)
-1.25 (-0.29%)
Weekly Expected Move ±3.8%
₹397
₹414
₹430
₹447
₹463
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap₹588.3B ($6.1B)
52W Range327.6-436.9
Volume3,777,385
Avg Volume4,297,056
Beta0.23
Dividend₹0.50
Analyst Ratings
No analyst coverage
Company Info
CEOShreehas Pradeep Tambe MTech
Employees16,315
SectorHealthcare
IndustryBiotechnology
IPO Date2004-04-07
Websitebiocon.com
20th KM, Hosur Road
Bengaluru 560100
IN
Bengaluru 560100
IN
91 80 2808 2808
About Biocon Limited
Biocon Limited, a biopharmaceutical company, manufactures pharmaceuticals, and medicinal chemical and botanical products. The company operates through Generics, Novel Biologics, Biosimilars, and Research Services segments. It focuses in the areas of diabetes, oncology, immunology, ophthalmology, and bone health diseases. In addition, It is involved in the integrated discovery, development, and manufacturing services for small and large molecules. The company serves customers in approximately 120 countries. Biocon Limited was founded in 1978 and is headquartered in Bengaluru, India.
Latest News
No recent news
Recent Insider Trades
No insider trades found